CD38 and Miyoshi myopathy: In addition, the use of immunomodulatory drugs (IMID), such as thalidomide, lenalidomide, and pomalidomide, resulted in the upregulation of CD38 on MM cells, causing them to trigger Daratumumab-induced NK cell-mediated ADCC (41, 42).